Truly a ”Care Team Forum®,” this roundtable discussion brings together a leading team of experts from a multidisciplinary atopic dermatitis (AD) clinic to talk about best practices in the treatment of pediatric AD. The panel is joined by a mother of a preteen daughter with severe AD who details her journey with multiple atopic disorders since infancy. The team discusses updates in the understanding of the pathophysiology of AD, the atopic march, updates in the treatment of pediatric AD, and exciting treatment options on the horizon. They also share how they coordinate care in between members of their interprofessional and multidisciplinary team.
Upon completion of this activity, participants should be better able to:
Identify the role of type 2 inflammation in the pathogenesis of moderate-to-severe atopic dermatitis (AD) and other atopic diseases
Apply key data on available and emerging biologic therapies for the treatment of moderate-to-severe AD in children
Integrate the unique roles and responsibilities of the interprofessional care team when managing common comorbidities in children with moderate-to-severe AD
Voluntary Associate Clinical Professor, Allergy & Immunology
Co-Director, AAFA-sponsored Severe Asthma Program
Rady Children’s Hospital
Allergy/Immunology Director, Multidisciplinary Atopic Dermatitis Program
University of California San Diego
President, San Diego Allergy Society
San Diego, CA
Eczema Educator/Lead Clinical Research Coordinator
Rady Children’s Hospital
Director, Grants and Rare Disease
Allergy and Asthma Medical Group and Research Center
Executive Director, San Diego Allergy Society
San Diego, CA
Assistant Professor, Department of Dermatology
University of California San Diego
San Diego, CA
Clinic Coordinator, Multidisciplinary Atopic Dermatitis Program
Rady Children’s Hospital
San Diego, CA
Featured RMEI CE Activities
Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources
